Methyl 2-(5-(3-chlorophenyl)-3-methyl-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetate

Catalog No. :
ACTKOQ155
CAS No. :
1035170-09-2
Molecular Formula :
C18H16ClN3O2
Molecular Weight :
341.80

IUPAC Name:methyl 2-(5-(3-chlorophenyl)-3-methyl-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetate

Methyl 2-(5-(3-chlorophenyl)-3-methyl-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$728.00Login to see priceInquiryInquiry
25mg98%$1400.00Login to see priceInquiryInquiry
50mg98%$2154.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(5-(3-chlorophenyl)-3-methyl-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetate
IUPAC Namemethyl 2-(5-(3-chlorophenyl)-3-methyl-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetate
Molecular FormulaC18H16ClN3O2
Molecular Weight341.80
SMILESO=C(OC)CC1=C(C2=CC=CC(Cl)=C2)N(C3=CC=CN=C3)N=C1C
InChI KeyFHHRBSBYDPLQRA-UHFFFAOYSA-N
Synonym1H-Pyrazole-4-acetic acid, 5-(3-chlorophenyl)-3-methyl-1-(3-pyridinyl)-, methyl ester;methyl 2-[5-(3-chlorophenyl)-3-methyl-1-(pyridin-3-yl)pyrazol-4-yl]acetate - [AC80100]
CAS No.1035170-09-2

Synthetic Route by SureRoute

1. ACTKOQ155 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHOKA215 route compound structure diagram
    ACHOKA215364727-74-2 In Stock
  4. Then
  5. ACTKOQ155 route product structure diagram
    ACTKOQ1551035170-09-2
Inquiry

2. ACTKOQ155 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACHOKA215 route compound structure diagram
    ACHOKA215364727-74-2 In Stock
  6. Then
  7. ACTKOQ155 route product structure diagram
    ACTKOQ1551035170-09-2
Inquiry

Comments (0)